SEC Company Response from Enveric Biosciences, Inc. (ENVB) (CIK 0000890821) (ENVB) — Nov 8, 2017
Enveric Biosciences, Inc. (ENVB) (CIK 0000890821)
Date: Nov. 8, 2017 · CIK: 0000890821 · Accession: 0001193805-17-003420
AI Filing Summary & Sentiment
File numbers found in text: 333-220499
Show Raw Text
CORRESP
1
filename1.htm
November 8, 2017
VIA EMAIL AND EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E., Mail Stop 3030
Washington, D.C. 20549
Attention:
Amanda Ravitz
Assistant Director
c/o Caleb French
Re: Ameri Holdings, Inc.
Registration Statement on Form S-1 (No. 333-220499)
Ladies and Gentlemen:
On behalf of Ameri Holdings, Inc. (the “Company”),
we enclose the Company’s request for acceleration of the above-referenced Registration Statement to 3:00 p.m., Eastern time,
on Wednesday, November 9, 2017, or as soon as possible thereafter, and acknowledgement of the statements contained in the U.S.
Securities and Exchange Commission’s letters to the Company.
Please advise the undersigned of the effectiveness
of the Registration Statement.
Very truly yours,
/s/ Adam W. Finerman
Adam W. Finerman
cc: Mr. Giri Devanur
Mr. Viraj Patel
Ameri Holdings, Inc.
100 Canal Pointe Boulevard, Suite 108
Princeton, NJ 08540
November 8, 2017
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E., Mail Stop 3030
Washington, D.C. 20549
Attention:
Amanda Ravitz
Assistant Director
c/o Caleb French
Re: Ameri Holdings, Inc.
Registration Statement on Form S-1 (No. 333-220499)
Ladies and Gentlemen:
Ameri Holdings, Inc. (the “Company”)
hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective
at 3:00 p.m., Eastern time, on Wednesday, November 9, 2017, or as soon as possible thereafter.
In connection with the Company’s request
for acceleration of the effective date of the Registration Statement, the Company acknowledges:
· should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose
the U.S. Securities and Exchange Commission (the “SEC”) from taking any action with respect to the filing;
· the action of the SEC or its staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve
the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by
the SEC or any person under the federal securities laws of the United States.
Very truly yours,
AMERI HOLDING, INC.
By:
/s/ Viraj Patel
Viraj Patel
Chief Financial Officer